Literature DB >> 6229169

Percutaneous transluminal angioplasty for arterial disease of the lower extremities.

B T Katzen.   

Abstract

Percutaneous transluminal angioplasty has become an effective method of restoring blood flow and relieving symptoms of peripheral arterial disease in the lower limbs. It has the advantages of less pain, morbidity, and cost compared with surgery. Best results are in short stenotic lesions where the patency rate at 2 years in iliac, superficial femoral-popliteal arteries, and popliteal arteries is 85%-90%, 50%-75%, and 70%-80%, respectively. Complications of distal embolization, thrombosis, and perforation occur in 3%-5% of attempts and require immediate surgery. Some considerations for the selection of patients, approach, technique, and use of drugs to control arterial spasm and thrombosis are reviewed briefly.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229169     DOI: 10.2214/ajr.142.1.23

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  The use of double guidewires through a single vascular sheath for obtaining profunda femoris arterial access: technical note.

Authors:  A J Zito; G P Teitelbaum; A H Matsumoto; K H Barth
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Apr-May       Impact factor: 2.740

2.  Claudication.

Authors:  V C Ruckley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

3.  Intraoperative angioplasty.

Authors:  G Wilms; A Nevelsteen; A Baert; R Suy
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

4.  Percutaneous balloon pulmonary valvuloplasty.

Authors:  M Tynan; E J Baker; J Rohmer; O D Jones; J F Reidy; M C Joseph; J Ottenkamp
Journal:  Br Heart J       Date:  1985-05

5.  Percutaneous transluminal angioplasty of the subclavian artery: early and late results.

Authors:  G Wilms; A Baert; D Dewaele; J Vermylen; A Nevelsteen; R Suy
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.